[Form 4] AVANOS MEDICAL, INC. Insider Trading Activity

Avanos Medical, Inc. principal accounting officer John Joseph Hurley reported equity award activity in company common stock.

Rhea-AI Filing Summary

Avanos Medical, Inc. principal accounting officer John Joseph Hurley reported equity award activity in company common stock. On March 6, 2026, 919 performance-based restricted share units vested, resulting in the acquisition of 919 shares at $13.79 per share through an exercise of derivative securities.

On the same date, Hurley surrendered 321, 144, and 211 shares of common stock to the issuer to satisfy tax withholding obligations tied to the vesting of the 919 performance-based RSUs and time-based RSUs of 413 and 604 units. After these transactions, he directly owned 11,607 shares of Avanos common stock.

Insider Trade Summary

4 transactions reported

Mixed 4 txns

Insider Hurley John Joseph

Role Principal Accounting Officer

Type	Security	Shares	Price	Value
Exercise	Common Stock	919	$13.79	$13K
Exercise Price or Tax Liability	Common Stock	321	$13.79	$4K
Exercise Price or Tax Liability	Common Stock	144	$13.79	$2K
Exercise Price or Tax Liability	Common Stock	211	$13.79	$3K

Holdings After Transaction: Common Stock — 11,607 shares (Direct)

Footnotes (4)

1. F1. Represents performance-based restricted share units (PRSUs) which: (i) were awarded to the Reporting Person on March 6, 2023 and (ii) vested on March 6, 2026. Each PRSU is the economic eqiuvalent of one share of Common Stock.
2. F2. Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 919 PRSUs which vested on March 6, 2026.
3. F3. Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 413 time-based restricted share units (TRSUs) which: (i) were awarded to the Reporting Person on March 6, 2023 and (ii) vested on March 6, 2026. Each TRSU is the economic equivalent of one share of Common Stock.
4. F4. Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 604 TRSUs which: (i) were awarded to the Reporting Person on March 6, 2024 and (ii) vested on March 6, 2026. Each TRSU is the economic equivalent of one share of Common Stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/10/2026 - 09:49 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hurley John Joseph

(Last) (First) (Middle)

5405 WINDWARD PARKWAY

SUITE 100

(Street)

ALPHARETTA GA 30004

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AVANOS MEDICAL, INC. [ AVNS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Principal Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/06/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/06/2026		M		919(1)	A	$13.79	12,283	D
Common Stock	03/06/2026		F(2)		321	D	$13.79	11,962	D
Common Stock	03/06/2026		F(3)		144	D	$13.79	11,818	D
Common Stock	03/06/2026		F(4)		211	D	$13.79	11,607	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents performance-based restricted share units (PRSUs) which: (i) were awarded to the Reporting Person on March 6, 2023 and (ii) vested on March 6, 2026. Each PRSU is the economic eqiuvalent of one share of Common Stock.

2. Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 919 PRSUs which vested on March 6, 2026.

3. Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 413 time-based restricted share units (TRSUs) which: (i) were awarded to the Reporting Person on March 6, 2023 and (ii) vested on March 6, 2026. Each TRSU is the economic equivalent of one share of Common Stock.

4. Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 604 TRSUs which: (i) were awarded to the Reporting Person on March 6, 2024 and (ii) vested on March 6, 2026. Each TRSU is the economic equivalent of one share of Common Stock.

Remarks:

	/s/ John S. Fischer, as attorney-in-fact for John Joseph Hurley	03/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.